Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Fournier

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Psychophysiology|February 4, 2016
The gap-startle paradigm to assess auditory temporal processing: Bridging animal and human researchPhilippe Fournier, Sylvie Hébert
Frontiers in Oncology|December 16, 2014
Harnessing oncolytic virus-mediated anti-tumor immunityVolker Schirrmacher, Philippe Fournier
Frontiers in Oncology|October 14, 2014
Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodiesVolker Schirrmacher, Philippe Fournier
Frontiers in Neurology|March 9, 2017
Clinical Validation of a New Tinnitus Assessment TechnologySylvie Hébert, Philippe Fournier
Clinical & Developmental Immunology|March 16, 2011
Tumor antigen-dependent and tumor antigen-independent activation of antitumor activity in T cells by a bispecific antibody-modified tumor vaccinePhilippe Fournier, Volker Schirrmacher
Psychophysiology|December 28, 2020
The gap prepulse inhibition of the acoustic startle (GPIAS) paradigm to assess auditory temporal processing: Monaural versus binaural presentationPhilippe Fournier, Sylvie Hébert
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2013
Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the futurePhilippe Fournier, Volker Schirrmacher
Biology|May 17, 2014
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostPhilippe Fournier, Volker Schirrmacher
Expert Review of Vaccines|December 20, 2008
Randomized clinical studies of anti-tumor vaccination: state of the art in 2008Philippe Fournier, Volker Schirrmacher
Expert Review of Vaccines|April 8, 2010
Danger signals in tumor cells: a risk factor for autoimmune disease?Volker Schirrmacher, Philippe Fournier
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Psychophysiology|February 4, 2016
The gap-startle paradigm to assess auditory temporal processing: Bridging animal and human researchPhilippe Fournier, Sylvie Hébert
Frontiers in Oncology|December 16, 2014
Harnessing oncolytic virus-mediated anti-tumor immunityVolker Schirrmacher, Philippe Fournier
Frontiers in Oncology|October 14, 2014
Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodiesVolker Schirrmacher, Philippe Fournier
Frontiers in Neurology|March 9, 2017
Clinical Validation of a New Tinnitus Assessment TechnologySylvie Hébert, Philippe Fournier
Clinical & Developmental Immunology|March 16, 2011
Tumor antigen-dependent and tumor antigen-independent activation of antitumor activity in T cells by a bispecific antibody-modified tumor vaccinePhilippe Fournier, Volker Schirrmacher
Psychophysiology|December 28, 2020
The gap prepulse inhibition of the acoustic startle (GPIAS) paradigm to assess auditory temporal processing: Monaural versus binaural presentationPhilippe Fournier, Sylvie Hébert
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2013
Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the futurePhilippe Fournier, Volker Schirrmacher
Biology|May 17, 2014
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostPhilippe Fournier, Volker Schirrmacher
Expert Review of Vaccines|December 20, 2008
Randomized clinical studies of anti-tumor vaccination: state of the art in 2008Philippe Fournier, Volker Schirrmacher
Expert Review of Vaccines|April 8, 2010
Danger signals in tumor cells: a risk factor for autoimmune disease?Volker Schirrmacher, Philippe Fournier
Pageof 13